Wolverine Trading, LLC Aerie Pharmaceuticals Inc Call Options Transaction History

Wolverine Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2020 Nov 13, 2020	SELL	$10.46 - $14.46 $106,692 - $147,492	-10,200 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$12.0 - $16.13 $112,800 - $151,622	-9,400 Reduced 47.96%	10,200 $152,000
Q3 2019 Nov 14, 2019	SELL	$18.41 - $28.0 $5,523 - $8,400	-300 Reduced 1.51%	19,600 $399,000
Q2 2019 Aug 20, 2019	BUY	$28.97 - $48.21 $98,498 - $163,914	3,400 Added 20.61%	19,900 $588,000
Q1 2019 May 15, 2019	SELL	$36.32 - $49.25 $134,384 - $182,225	-3,700 Reduced 18.32%	16,500 $784,000
Q4 2018 Feb 14, 2019	BUY	$33.0 - $60.04 $254,100 - $462,308	7,700 Added 61.6%	20,200 $718,000
Q3 2018 Nov 14, 2018	BUY	$56.15 - $73.9 $701,875 - $923,750	12,500 New	12,500 $769,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.